Lucinda Dowling wins 2025 Tasmanian Intern Pharmacist award

The Pharmaceutical Society of Australia (PSA) has awarded Lucinda Dowling the 2025 Tasmanian Intern Pharmacist of the Year, recognising her leadership, commitment to patient care, and contributions to medicines safety.

‘Exceptional initiative in pharmacy delivery’

A pharmacist at the Royal Hobart Hospital and a recently graduated PSA intern, Ms Dowling has demonstrated exceptional initiative in pharmacy delivery.

Her work in medicines governance and access included vaccine prescribing and distribution, leading to updates in the Tasmanian Medication Formulary and guiding pharmacy supply decisions.

Ms Dowling has also played a key role in improving vancomycin level monitoring in the neurosurgery ward, identifying administration errors, and developing targeted education for nursing staff to enhance patient safety.

Beyond her clinical contributions, Ms Dowling has been a leader among her peers — mentoring new pharmacy interns, supervising University of Tasmania pharmacy students, and facilitating education sessions for fellow interns.

‘An incredible example of what it means to be a pharmacist’

PSA Tasmania President Mark Kirschbaum FPS praised Ms Dowling for her dedication to advancing pharmacy practice.

“Lucinda has set an incredible example of what it means to be a pharmacist — demonstrating leadership, initiative, and a dedication to medicines safety that will serve her well throughout her career,” he said.

‘On behalf of PSA, I congratulate Lucinda on this well-deserved recognition and look forward to continuing to support her throughout her undoubtedly bright pharmacy career ahead.”

The award was presented at the PSA Intern of the Year and Welcome to the Profession event on 21 February 2025 at T42 Hobart.

Must Read

Don't stop taking prescribed heart medications

‘Groundbreaking’: TGA approves weight loss drug for CVD

0
For the first time in Australia, a weight loss drug has been approved for treating cardiovascular disease (CVD) in overweight and obese patients. The Therapeutic...